BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16289368)

  • 1. Anti-atherogenic properties of fibrates may be largely due to their anti-inflammatory effects.
    Ye HJ; Zhao SP
    Med Hypotheses; 2006; 66(3):495-500. PubMed ID: 16289368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibrates and markers of inflammation].
    Broncel M
    Pol Merkur Lekarski; 2007 Jan; 22(127):58-61. PubMed ID: 17477093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
    Späh F
    Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory drugs and atherosclerosis.
    Moubayed SP; Heinonen TM; Tardif JC
    Curr Opin Lipidol; 2007 Dec; 18(6):638-44. PubMed ID: 17993809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory biomarkers of coronary atheromatous plaque vulnerability.
    Avanzas P; Arroyo-Espliguero R; Garcia-Moll X; Kaski JC
    Panminerva Med; 2005 Jun; 47(2):81-91. PubMed ID: 16210993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing anti-inflammatory cytokine IL-10 may be beneficial for acute coronary syndrome.
    Li JJ; Guo YL; Yang YJ
    Med Hypotheses; 2005; 65(1):103-6. PubMed ID: 15893126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adventitial lymphatic vessels -- an important role in atherosclerosis.
    Xu X; Lin H; Lv H; Zhang M; Zhang Y
    Med Hypotheses; 2007; 69(6):1238-41. PubMed ID: 17825501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The monocyte/macrophage as a therapeutic target in atherosclerosis.
    Saha P; Modarai B; Humphries J; Mattock K; Waltham M; Burnand KG; Smith A
    Curr Opin Pharmacol; 2009 Apr; 9(2):109-18. PubMed ID: 19230773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The two faces of the 15-lipoxygenase in atherosclerosis.
    Wittwer J; Hersberger M
    Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):67-77. PubMed ID: 17869078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of chronic inflammation in cardiovascular disease and its regulation by nutrients.
    Osiecki H
    Altern Med Rev; 2004 Mar; 9(1):32-53. PubMed ID: 15005643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cellular mechanisms of regulation of the inflammatory response in atherosclerosis: the role of cell contact-mediated signaling].
    Monaco C; Young S; Paleolog E; Maseri A; Feldmann M
    Ital Heart J Suppl; 2001 Apr; 2(4):339-43. PubMed ID: 19397004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the endocannabinoid system in atherosclerosis.
    Mach F; Steffens S
    J Neuroendocrinol; 2008 May; 20 Suppl 1():53-7. PubMed ID: 18426500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endothelium and inflammation.
    Trepels T; Zeiher AM; Fichtlscherer S
    Endothelium; 2006; 13(6):423-9. PubMed ID: 17169774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin and obestatin modulate early atherogenic processes on cells: enhancement of monocyte adhesion and oxidized low-density lipoprotein binding.
    Kellokoski E; Kunnari A; Jokela M; Mäkelä S; Kesäniemi YA; Hörkkö S
    Metabolism; 2009 Nov; 58(11):1572-80. PubMed ID: 19608205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.
    Isoda K; Young JL; Zirlik A; MacFarlane LA; Tsuboi N; Gerdes N; Schönbeck U; Libby P
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):611-7. PubMed ID: 16385087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes.
    Woo HM; Kang JH; Kawada T; Yoo H; Sung MK; Yu R
    Life Sci; 2007 Feb; 80(10):926-31. PubMed ID: 17196622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutical effects of PPAR agonists assessed by biomarker modulation.
    Chinetti-Gbaguidi G; Fruchart JC; Staels B
    Biomarkers; 2005 Nov; 10 Suppl 1():S30-6. PubMed ID: 16298909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.
    Sukhanov S; Higashi Y; Shai SY; Vaughn C; Mohler J; Li Y; Song YH; Titterington J; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2684-90. PubMed ID: 17916769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-atherosclerotic effect of fibrates and eicosapentaenoic acid].
    Sakamoto Y; Node K
    Nihon Rinsho; 2011 Jan; 69(1):87-91. PubMed ID: 21226266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.